(-0.13%) 5 140.50 points
(-0.10%) 38 519 points
(-0.07%) 17 892 points
(0.19%) $82.79
(2.71%) $2.09
(-1.37%) $2 325.40
(-2.64%) $26.93
(-1.07%) $951.20
(0.21%) $0.934
(0.49%) $11.04
(0.20%) $0.798
(0.00%) $93.30
11.36% $ 5.00
Live Chart Being Loaded With Signals
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers...
Stats | |
---|---|
Dzisiejszy wolumen | 163 052 |
Średni wolumen | 731 881 |
Kapitalizacja rynkowa | 192.73M |
EPS | $0.220 ( 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.45 |
ATR14 | $0.559 (17.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Pelletier Nadege | Buy | 105 000 | Share Option (Right to Buy) |
2024-01-02 | Griffiths Graham | Buy | 96 500 | Share Option (Right to Buy) |
2024-01-02 | Enright William | Buy | 443 981 | Share Option (Right to Buy) |
2024-01-02 | Brown Gemma | Buy | 193 000 | Share Option (Right to Buy) |
2023-06-26 | Scheeren Joseph | Buy | 10 000 | Ordinary Shares |
INSIDER POWER |
---|
41.32 |
Last 95 transactions |
Buy: 18 963 250 | Sell: 20 685 755 |
Wolumen Korelacja
Vaccitech plc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SVOK | 0.919 |
PAIC | 0.901 |
FORE | 0.872 |
RDUS | 0.87 |
SVAC | 0.858 |
RMRM | 0.857 |
SPRT | 0.835 |
TLGT | 0.834 |
EPZM | 0.829 |
IVA | 0.828 |
10 Najbardziej negatywne korelacje | |
---|---|
NETE | -0.908 |
BOCH | -0.876 |
RAVN | -0.866 |
AMRB | -0.862 |
HRMY | -0.852 |
SBBP | -0.847 |
MMAC | -0.843 |
CFMS | -0.835 |
SFST | -0.829 |
AEPPZ | -0.827 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vaccitech plc Korelacja - Waluta/Towar
Vaccitech plc Finanse
Annual | 2022 |
Przychody: | $44.70M |
Zysk brutto: | $2.35M (5.26 %) |
EPS: | $0.140 |
FY | 2022 |
Przychody: | $44.70M |
Zysk brutto: | $2.35M (5.26 %) |
EPS: | $0.140 |
FY | 2021 |
Przychody: | $268 000 |
Zysk brutto: | $268 000 (100.00 %) |
EPS: | $-1 067.56 |
FY | 2020 |
Przychody: | $4.82M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-371.62 |
Financial Reports:
No articles found.
Vaccitech plc
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej